Sanofi India Ltd
SANOFISanofi India Ltd
SANOFI
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 30.77 | 13.93 | 2.72% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.23 | 6.64 | 0.52% |
Forecast & Ratings
Detailed Forecast from 3 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Mankind Pharma Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2023 | TTM | ||
|---|---|---|---|---|
| Total Revenue | 2,934.20 | 2,314.40 | ||
Raw Materials | 1,493.40 | 1,678.00 | ||
| Power & Fuel Cost | 14.60 | |||
| Employee Cost | 370.60 | |||
| Selling & Administrative Expenses | 332.90 | |||
| Operating & Other expenses | -164.10 | |||
EBITDA | 886.80 | 636.40 | ||
| Depreciation/Amortization | 39.60 | 37.30 | ||
| PBIT | 847.20 | 599.10 | ||
| Interest & Other Items | 1.70 | 1.50 | ||
| PBT | 845.50 | 597.60 | ||
| Taxes & Other Items | 242.60 | 137.90 | ||
| Net Income | 602.90 | 459.70 | ||
| EPS | 261.78 | 199.60 | ||
| DPS | 167.00 | 104.45 | ||
| Payout ratio | 0.64 | 0.52 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sanofi India Ltd | 23.46 | 13.93 | 2.72% |
| Sun Pharmaceutical Industries Ltd | 45.62 | 6.51 | 0.74% |
| Mankind Pharma Ltd | 62.83 | 12.55 | — |
| Cipla Ltd | 28.94 | 4.45 | 0.88% |
Price Comparison
Compare SANOFI with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Sanofi India Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI MAGNUM MIDCAP FUND DIRECT PL GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8073% | Percentage of the fund’s portfolio invested in the stock 1.19% | Change in the portfolio weight of the stock over the last 3 months 0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 20/82 (+1) |
Aditya Birla Sun Life Frontline Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1141% | Percentage of the fund’s portfolio invested in the stock 0.54% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 46/96 (0) |
Nippon India Pharma Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.0465% | Percentage of the fund’s portfolio invested in the stock 1.70% | Change in the portfolio weight of the stock over the last 3 months -0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/38 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateMay 3, 2024
Dividend/Share
₹117.00
Ex DateEx Date
May 3, 2024
Cash Dividend
Ex DateEx DateMar 7, 2024
Dividend/Share
₹50.00
Ex DateEx Date
Mar 7, 2024
Cash Dividend
Ex DateEx DateApr 28, 2023
Dividend/Share
₹183.00
Ex DateEx Date
Apr 28, 2023
Cash Dividend
Ex DateEx DateApr 28, 2023
Dividend/Share
₹194.00
Ex DateEx Date
Apr 28, 2023
Cash Dividend
Ex DateEx DateAug 5, 2022
Dividend/Share
₹193.00
Ex DateEx Date
Aug 5, 2022
Net profit of Sanofi India declined 45.99% to Rs 82.20 crore in the quarter ended September 2024 as against Rs 152.20 crore during the previous quarter ended September 2023. Sales rose 6.79% to Rs 524.00 crore in the quarter ended September 2024 as against Rs 490.70 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales524.00490.70 7 OPM %22.8423.13 - PBDT121.60123.80 -2 PBT112.60114.60 -2 NP82.20152.20 -46 Powered by Capital Market - Live
Sanofi India will hold a meeting of the Board of Directors of the Company on 7 November 2024.Powered by Capital Market - Live
Sanofi India Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 7265.05, up 1.86% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.57% on the day, quoting at 25136.35. The Sensex is at 82165.57, down 0.47%. Sanofi India Ltd has risen around 13.34% in last one month. Meanwhile, Nifty Pharma index of which Sanofi India Ltd is a constituent, has risen around 6.86% in last one month and is currently quoting at 23014.3, up 0.21% on the day. The volume in the stock stood at 27179 shares today, compared to the daily average of 18790 shares in last one month.The PE of the stock is 33.42 based on TTM earnings ending June 24.Powered by Capital Market - Live
Sanofi gets drug regulator nod to market RSV therapy in India
Sanofi gets regulatory nod for RSV product in India
Sanofi India stock falls 2% on weak June quarter results; profit falls 16%
Sanofi India standalone net profit declines 15.87% in the June 2024 quarter
Net profit of Sanofi India declined 15.87% to Rs 103.40 crore in the quarter ended June 2024 as against Rs 122.90 crore during the previous quarter ended June 2023. Sales declined 9.98% to Rs 463.50 crore in the quarter ended June 2024 as against Rs 514.90 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales463.50514.90 -10 OPM %24.9623.62 - PBDT120.10136.40 -12 PBT111.10127.30 -13 NP103.40122.90 -16 Powered by Capital Market - Live
Sanofi India Ltd spurts 1.9%, rises for fifth straight session
Sanofi India Ltd gained for a fifth straight session today. The stock is quoting at Rs 6682, up 1.9% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.23% on the day, quoting at 24358.45. The Sensex is at 79975.9, down 0.22%. Sanofi India Ltd has slipped around 0.07% in last one month. Meanwhile, Nifty Pharma index of which Sanofi India Ltd is a constituent, has slipped around 7.16% in last one month and is currently quoting at 20908.5, up 0.17% on the day. The volume in the stock stood at 11821 shares today, compared to the daily average of 15692 shares in last one month.The PE of the stock is 26.61 based on TTM earnings ending March 24.Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant